• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

症状发作到首次就诊的时间间隔较长可导致巨细胞动脉炎患者永久性视力丧失:一项队列研究。

Long delay from symptom onset to first consultation contributes to permanent vision loss in patients with giant cell arteritis: a cohort study.

机构信息

Department of Rheumatology, University Hospital Basel, Basel, Switzerland.

Department of Angiology, University Hospital Basel, Basel, Switzerland.

出版信息

RMD Open. 2023 Jan;9(1). doi: 10.1136/rmdopen-2022-002866.

DOI:10.1136/rmdopen-2022-002866
PMID:36635003
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9843209/
Abstract

OBJECTIVES

To characterise factors associated with permanent vision loss (PVL) and potential reasons for the therapeutic delay contributing to PVL in giant cell arteritis (GCA).

METHODS

Retrospective analysis of GCA patients diagnosed at the University Hospital Basel between December 2006 and May 2021.

RESULTS

Of 282 patients with GCA (64% females), 49 (17.4%) experienced PVL. In 43/49 (87.8%) PVL occurred before treatment. Of these, 24 (55.8%) patients had first non-ocular symptoms and eventually sought consultation when PVL occurred in a median of 21 (IQR 14.75-31.0) days after the first symptoms. Only five of the 24 patients had consulted a physician before PVL, but GCA diagnosis was missed. Treatment was initiated rapidly after diagnosis (median 1 day (IQR 0.0-7.0)). PVL on therapy occurred in six patients in a median of 40 (IQR 20.5-67.3) days after treatment started. In two of those, glucocorticoids were tapered too quickly.In multivariable analysis, patients with PVL were older (OR 1.17, 95% CI 1.07 to 1.29, p=0.001) and reported more frequently jaw claudication (OR 3.52, 95% CI 1.02 to 13.16, p=0.051). PVL was present in 18 (42.9%) of the 42 patients with vasculitic ultrasound findings in all six temporal artery segments. The incidence of PVL over 15 years did not decline (Spearman rank=0.3, p=0.68).

CONCLUSION

The prevalence of GCA-associated PVL remains high. Associated factors were advanced age, jaw claudication and ultrasound findings consistent with vasculitis in all six temporal artery segments. Despite preceding non-ocular GCA symptoms weeks before the onset of PVL, most patients were not seen by a rheumatologist before PVL occurred.

摘要

目的

描述与巨细胞动脉炎(GCA)患者永久性视力丧失(PVL)相关的因素,以及导致 GCA 患者治疗延迟的潜在原因。

方法

对 2006 年 12 月至 2021 年 5 月期间在巴塞尔大学医院诊断为 GCA 的患者进行回顾性分析。

结果

282 例 GCA 患者中(64%为女性),49 例(17.4%)出现了 PVL。在 43/49 例(87.8%)PVL 发生在治疗之前。其中,24 例(55.8%)患者在出现 PVL 之前有非眼部症状,在中位 21 天(IQR 14.75-31.0)后最终就诊,首次出现症状。24 例患者中只有 5 例在 PVL 之前咨询过医生,但未确诊 GCA。诊断后迅速开始治疗(中位时间 1 天(IQR 0.0-7.0))。6 例患者在治疗开始后中位 40 天(IQR 20.5-67.3)时发生了治疗相关的 PVL,其中 2 例患者糖皮质激素减量过快。多变量分析显示,发生 PVL 的患者年龄更大(OR 1.17,95%CI 1.07 至 1.29,p=0.001),更常报告咀嚼困难(OR 3.52,95%CI 1.02 至 13.16,p=0.051)。42 例患者的所有 6 条颞动脉节段均有血管炎超声表现,其中 18 例(42.9%)出现了 PVL。15 年内 PVL 的发生率并未下降(Spearman 秩=0.3,p=0.68)。

结论

GCA 相关的 PVL 患病率仍然很高。相关因素包括年龄较大、咀嚼困难和所有 6 条颞动脉节段均有超声检查符合血管炎的表现。尽管在 PVL 发生之前,几周前就出现了非眼部 GCA 症状,但大多数患者在 PVL 发生之前并未就诊于风湿病医生。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cb2/9843209/16e3a3ed8f4d/rmdopen-2022-002866f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cb2/9843209/8d915a592206/rmdopen-2022-002866f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cb2/9843209/0443617649fd/rmdopen-2022-002866f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cb2/9843209/16e3a3ed8f4d/rmdopen-2022-002866f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cb2/9843209/8d915a592206/rmdopen-2022-002866f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cb2/9843209/0443617649fd/rmdopen-2022-002866f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cb2/9843209/16e3a3ed8f4d/rmdopen-2022-002866f03.jpg

相似文献

1
Long delay from symptom onset to first consultation contributes to permanent vision loss in patients with giant cell arteritis: a cohort study.症状发作到首次就诊的时间间隔较长可导致巨细胞动脉炎患者永久性视力丧失:一项队列研究。
RMD Open. 2023 Jan;9(1). doi: 10.1136/rmdopen-2022-002866.
2
Features and risk factors for new (secondary) permanent visual involvement in giant cell arteritis.巨细胞动脉炎中新(继发)永久性视力受累的特征和危险因素。
Clin Exp Rheumatol. 2022 May;40(4):734-740. doi: 10.55563/clinexprheumatol/btj1ia. Epub 2022 May 4.
3
Do Early Diagnosis and Glucocorticoid Treatment Decrease the Risk of Permanent Visual Loss and Early Relapses in Giant Cell Arteritis: A Prospective Longitudinal Study.早期诊断和糖皮质激素治疗能否降低巨细胞动脉炎患者永久性视力丧失和早期复发的风险:一项前瞻性纵向研究
Medicine (Baltimore). 2016 Apr;95(14):e3210. doi: 10.1097/MD.0000000000003210.
4
Characterization of visual manifestations and identification of risk factors for permanent vision loss in patients with giant cell arteritis.巨细胞动脉炎患者视力丧失的视觉表现特征及危险因素分析。
Clin Rheumatol. 2021 Aug;40(8):3207-3217. doi: 10.1007/s10067-021-05643-5. Epub 2021 Feb 12.
5
Ocular ischaemic complications in giant cell arteritis: CHADS2-score predicts risk of permanent visual impairment.巨细胞动脉炎的眼部缺血性并发症:CHADS2 评分可预测永久性视力损害的风险。
Clin Exp Rheumatol. 2019 Mar-Apr;37 Suppl 117(2):61-64. Epub 2019 May 21.
6
Temporal Arteritis Revealing Antineutrophil Cytoplasmic Antibody-Associated Vasculitides: A Case-Control Study.巨细胞动脉炎合并抗中性粒细胞胞质抗体相关性血管炎:一项病例对照研究。
Arthritis Rheumatol. 2021 Feb;73(2):286-294. doi: 10.1002/art.41527. Epub 2020 Dec 21.
7
Visual improvement with corticosteroid therapy in giant cell arteritis. Report of a large study and review of literature.糖皮质激素治疗巨细胞动脉炎的视力改善。一项大型研究报告及文献综述。
Acta Ophthalmol Scand. 2002 Aug;80(4):355-67. doi: 10.1034/j.1600-0420.2002.800403.x.
8
Diagnostic delay in patients with giant cell arteritis: results of a fast-track clinic.巨细胞动脉炎患者的诊断延迟:快诊诊所的结果。
Clin Rheumatol. 2024 Jan;43(1):349-355. doi: 10.1007/s10067-023-06739-w. Epub 2023 Aug 31.
9
Rapid glucocorticoid tapering regimen in patients with giant cell arteritis: a single centre cohort study.巨细胞动脉炎患者的快速糖皮质激素递减方案:一项单中心队列研究。
RMD Open. 2023 Jul;9(3). doi: 10.1136/rmdopen-2023-003301.
10
Visual manifestations in giant cell arteritis: trend over 5 decades in a population-based cohort.巨细胞动脉炎的视觉表现:基于人群队列50年的趋势
J Rheumatol. 2015 Feb;42(2):309-15. doi: 10.3899/jrheum.140188. Epub 2014 Dec 15.

引用本文的文献

1
Prevalence, characteristics, and outcomes of patients with low baseline C-reactive protein in giant cell arteritis.巨细胞动脉炎中基线C反应蛋白水平较低患者的患病率、特征及预后
Arthritis Res Ther. 2025 Jul 30;27(1):162. doi: 10.1186/s13075-025-03594-9.
2
Atypical Signs and Symptoms of Giant Cell Arteritis: A Systematic Review.巨细胞动脉炎的非典型体征和症状:一项系统综述
J Gen Intern Med. 2025 Feb;40(3):659-665. doi: 10.1007/s11606-024-09141-7. Epub 2024 Oct 31.
3
Giant Cell Arteritis: Can Simple Ultrasound Examination Prevent Complex Consequences?

本文引用的文献

1
Features and risk factors for new (secondary) permanent visual involvement in giant cell arteritis.巨细胞动脉炎中新(继发)永久性视力受累的特征和危险因素。
Clin Exp Rheumatol. 2022 May;40(4):734-740. doi: 10.55563/clinexprheumatol/btj1ia. Epub 2022 May 4.
2
Ocular Complications of Giant Cell Arteritis: An Acute Therapeutic Emergency.巨细胞动脉炎的眼部并发症:一种急性治疗急症
J Clin Med. 2022 Apr 2;11(7):1997. doi: 10.3390/jcm11071997.
3
Fast-Track Ultrasound Clinic for the Diagnosis of Giant Cell Arteritis Changes the Prognosis of the Disease but Not the Risk of Future Relapse.
巨细胞动脉炎:简单的超声检查能否预防复杂后果?
Diagnostics (Basel). 2024 Sep 19;14(18):2071. doi: 10.3390/diagnostics14182071.
4
The use of intravenous methylprednisolone in giant cell arteritis: a population-based study.静脉注射甲基强的松龙在巨细胞动脉炎中的应用:一项基于人群的研究。
Rheumatology (Oxford). 2025 Apr 1;64(4):2083-2090. doi: 10.1093/rheumatology/keae459.
5
The spectrum of giant cell arteritis through a rheumatology lens.巨细胞动脉炎的风湿科视角。
Eye (Lond). 2024 Aug;38(12):2437-2447. doi: 10.1038/s41433-024-03153-7. Epub 2024 Jun 19.
6
Comparing Diagnostic Performance of Short and Long [F]FDG-PET Acquisition Times in Giant Cell Arteritis.比较短时间和长时间[F]FDG-PET采集时间在巨细胞动脉炎中的诊断性能
Diagnostics (Basel). 2023 Dec 27;14(1):62. doi: 10.3390/diagnostics14010062.
7
Prior polymyalgia rheumatica is associated with sonographic vasculitic changes in newly diagnosed patients with giant cell arteritis.先前的巨细胞动脉炎合并多发性肌痛与新诊断的巨细胞动脉炎患者的超声血管炎改变有关。
Rheumatology (Oxford). 2024 May 3;63(6):1523-1527. doi: 10.1093/rheumatology/kead450.
8
An atypical presentation of giant cell arteritis: Fatigable signs to anterior ischemic optic neuropathy and choroidal infarction.巨细胞动脉炎的非典型表现:前缺血性视神经病变和脉络膜梗死的易疲劳体征。
Clin Case Rep. 2023 Aug 6;11(8):e7775. doi: 10.1002/ccr3.7775. eCollection 2023 Aug.
9
Rapid glucocorticoid tapering regimen in patients with giant cell arteritis: a single centre cohort study.巨细胞动脉炎患者的快速糖皮质激素递减方案:一项单中心队列研究。
RMD Open. 2023 Jul;9(3). doi: 10.1136/rmdopen-2023-003301.
用于诊断巨细胞动脉炎的快速超声诊所改变了疾病的预后,但未改变未来复发风险。
Front Med (Lausanne). 2020 Dec 8;7:589794. doi: 10.3389/fmed.2020.589794. eCollection 2020.
4
Risk factors for severe cranial ischaemic complications in giant cell arteritis.巨细胞动脉炎严重颅缺血性并发症的危险因素。
Rheumatology (Oxford). 2020 Oct 1;59(10):2953-2959. doi: 10.1093/rheumatology/keaa058.
5
Novel ultrasonographic Halo Score for giant cell arteritis: assessment of diagnostic accuracy and association with ocular ischaemia.新型巨细胞动脉炎超声 Halo 评分:诊断准确性评估及其与眼部缺血的关系。
Ann Rheum Dis. 2020 Mar;79(3):393-399. doi: 10.1136/annrheumdis-2019-216343. Epub 2020 Jan 3.
6
2018 Update of the EULAR recommendations for the management of large vessel vasculitis.2018 年版 EULAR 大血管血管炎管理建议更新。
Ann Rheum Dis. 2020 Jan;79(1):19-30. doi: 10.1136/annrheumdis-2019-215672. Epub 2019 Jul 3.
7
Ocular ischaemic complications in giant cell arteritis: CHADS2-score predicts risk of permanent visual impairment.巨细胞动脉炎的眼部缺血性并发症:CHADS2 评分可预测永久性视力损害的风险。
Clin Exp Rheumatol. 2019 Mar-Apr;37 Suppl 117(2):61-64. Epub 2019 May 21.
8
Vessel wall plasticity in large vessel giant cell arteritis: an ultrasound follow-up study.大血管巨细胞动脉炎中血管壁的可塑性:一项超声随访研究。
Rheumatology (Oxford). 2019 May 1;58(5):792-797. doi: 10.1093/rheumatology/key383.
9
[18F]FDG positron emission tomography in patients presenting with suspicion of giant cell arteritis-lessons from a vasculitis clinic.[18F]FDG 正电子发射断层扫描在怀疑巨细胞动脉炎患者中的应用——来自血管炎门诊的经验。
Eur Heart J Cardiovasc Imaging. 2018 Aug 1;19(8):933-940. doi: 10.1093/ehjci/jex259.
10
Diagnostic delay for giant cell arteritis - a systematic review and meta-analysis.巨细胞动脉炎的诊断延迟——一项系统评价与荟萃分析
BMC Med. 2017 Jun 28;15(1):120. doi: 10.1186/s12916-017-0871-z.